# A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis

> **NCT07688772** · PHASE3 · RECRUITING · sponsor: **Guangdong Hengrui Pharmaceutical Co., Ltd** · enrollment: 196 (estimated)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** SHR-1819 Injection
- **DRUG:** SHR-1819 Injection Placebo

## Key facts

- **NCT ID:** NCT07688772
- **Lead sponsor:** Guangdong Hengrui Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-11
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2026-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07688772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07688772, "A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07688772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*